Regulation of lymphoid-specific immunoglobulin mu heavy chain gene enhancer by ETS-domain proteins
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
The enhancer for the immunoglobulin mu heavy chain gene (IgH) activates a heterologous gene at the pre-B cell stage of B lymphocyte differentiation. A lymphoid-specific element, microB, is necessary for enhancer function in pre-B cells. A microB binding protein is encoded by the PU.1/Spi-1 proto-oncogene. Another sequence element, microA, was identified in the mu enhancer that binds the product of the ets-1 proto-oncogene. The microA motif was required for microB-dependent enhancer activity, which suggests that a minimal B cell-specific enhancer is composed of both the PU.1 and Ets-1 binding sites. Co-expression of both PU.1 and Ets-1 in nonlymphoid cells trans-activated reporter plasmids that contained the minimal mu enhancer. These results implicate two members of the Ets family in the activation of IgH gene expression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In case of the B-lymphoid genes such as Ig heavy chain (μ) [34], Ig light chains (κ and λ) [35, 36], mb- (Ig α) [37], B29 (Ig β) [38] and Ig-J chain [33], the binding of PU.1 to the enhancer regions induces the bending of DNA that facilitates the binding of other transcription factors to their respective binding sites, thus forming a synergistic multiprotein-complex to augment transcription.”
From PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis (2009) · cites this paper as [34]
Citations
Cites
A new technique for the assay of infectivity of human adenovirus 5 DNA
Graham, F. L., & van der Eb, A. J. (1973) · Virology · doi:10.1016/0042-6822(73)90341-3 · Cited by 9,451
Multiple nuclear factors interact with the immunoglobulin enhancer sequences
Sen, R., & Baltimore, D. (1986) · Cell · doi:10.1016/0092-8674(86)90346-6 · Cited by 2,752
Self-citationThe c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
Adams, J. M., Harris, A. W., Pinkert, C. A., Corcoran, L. M., Alexander, W. S., Cory, S., Palmiter, R. D., & Brinster, R. L. (1985) · Nature · doi:10.1038/318533a0 · Cited by 1,779
The myoD Gene Family: Nodal Point During Specification of the Muscle Cell Lineage
Weintraub, H., Davis, R., Tapscott, S., Thayer, M., Krause, M., Benezra, R., Blackwell, T. K., Turner, D., Rupp, R., Hollenberg, S., et al. (1991) · Science · doi:10.1126/science.1846704 · Cited by 1,572
The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene
Klemsz, M. J., McKercher, S. R., Celada, A., Van Beveren, C., & Maki, R. A. (1990) · Cell · doi:10.1016/0092-8674(90)90219-5 · Cited by 954
Self-citationLopata, M. A., Cleveland, D. W., & Sollner-Webb, B. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.14.5707 · Cited by 822
B Lineage—Specific Interactions of an Immunoglobulin Enhancer with Cellular Factors in Vivo
Ephrussi, A., Church, G. M., Tonegawa, S., & Gilbert, W. (1985) · Science · doi:10.1126/science.3917574 · Cited by 796
Developmentally controlled and tissue-specific expression of unrearranged VH gene segments
Yancopoulos, G. (1985) · Cell · doi:10.1016/0092-8674(85)90141-2 · Cited by 696
Protein-Binding Sites in Ig Gene Enhancers Determine Transcriptional Activity and Inducibility
Lenardo, M., Pierce, J. W., & Baltimore, D. (1987) · Science · doi:10.1126/science.3109035 · Cited by 578
The ETS-domain: a new DNA-binding motif that recognizes a purine-rich core DNA sequence.
Karim, F. D., Urness, L. D., Thummel, C. S., Klemsz, M. J., McKercher, S. R., Celada, A., Van Beveren, C., Maki, R. A., Gunther, C. V., & Nye, J. A. (1990) · Genes & Development · doi:10.1101/gad.4.9.1451 · Cited by 499
Self-citation
Cited by
Items 101–200 of 217
Analysis of Gene Expression and Ig Transcription in PU.1/Spi-B-Deficient Progenitor B Cell Lines
Schweitzer, B. L., & DeKoter, R. P. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.1.144 · Cited by 52
“1 interacts with the intronic enhancer but not the 3 enhancer region (27), and therefore the 3 enhancer may likewise be able to compensate for loss of activity of the intronic enhancer.”
BackgroundRao, E., Dang, W., Tian, G., & Sen, R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.10.6722 · Cited by 51
Self-citationRobinson, L., Panayiotakis, A., Papas, T. S., Kola, I., & Seth, A. K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7170 · Cited by 55
Bright/ARID3A contributes to chromatin accessibility of the immunoglobulin heavy chain enhancer
Lin, D., Ippolito, G. C., Zong, R.-T., Bryant, J., Koslovsky, J. S., & Tucker, P. W. (2007) · Molecular Cancer · doi:10.1186/1476-4598-6-23 · Cited by 51
Houston, I. B., Kamath, M. B., Schweitzer, B. L., Chlon, T. M., & DeKoter, R. P. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2007.04.005 · Cited by 49
“1 is expressed at high levels in myeloid lineage cells and at lower levels in B lymphocytes [1,2,6,7].”
BackgroundPCR Technique for Identification of Mussel Species
Rego‐Pérez, I., Martínez‐Lage, A., González‐Tizón, A. M., Vieites, J. M., Leira, F., & Méndez, J. (2002) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0110957 · Cited by 49
Tam, W. F., Wang, W., & Sen, R. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.14.4837-4846.2001 · Cited by 49
“Transfections. COS cell and BOSC23 cell transfection was done by the calcium phosphate method as previously described ( 32 ) or with Fugene-6 transfection reagent according to the manufacturer’s specifications (Roche Molecular Biochemicals).”
MethodSelf-citationThe ETS Family of Transcriptional Regulators
Ghysdael, J., & Boureux, A. (1997) · Oncogenes as Transcriptional Regulators · doi:10.1007/978-3-0348-8889-9_2 · Cited by 48
Cultured Endothelial Cells From Human Arteriovenous Malformations Have Defective Growth Regulation
Wautier, M., Boval, B., Chappey, O., Enjolras, O., Wernert, N., Merland, J. J., & Wautier, J. (1999) · Blood · doi:10.1182/blood.v94.6.2020 · Cited by 47
Zhang, C., Gadue, P., Scott, E., Atchison, M., & Poncz, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.42.26236 · Cited by 48
Transcriptional Regulation of Mouse μ Opioid Receptor Gene by PU.1
Hwang, C. K., Kim, C. S., Choi, H. S., McKercher, S. R., & Loh, H. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400755200 · Cited by 46
Rao, S., Matsumura, A., Yoon, J., & Simon, M. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.11115 · Cited by 47
Definition of a T-Cell Receptor β Gene Core Enhancer of V(D)J Recombination by Transgenic Mapping
Tripathi, R. K., Mathieu, N., Spicuglia, S., Payet‐Bornet, D., Verthuy, C., Bouvier, G., Depetris, D., Mattéi, M., Hempel, W. M., & Ferrier, P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.1.42-53.2000 · Cited by 47
“Despite all of these studies however, Eb structural and functional organization remains less well understood compared to regulatory elements from other lymphoid genes such as the Ig heavy-chain (IgH) intronic enhancer or the TCRa enhancer (23, 53 ).”
BackgroundDNA Methylation and Chromatin Structure Regulate PU.1 Expression
Amaravadi, L., & Klemsz, M. J. (1999) · DNA and Cell Biology · doi:10.1089/104454999314737 · Cited by 44
“A previous report had shown through Northern blot analysis that the 2052 cell line contains PU.1 mRNA (Nelsen et al. , 1993), suggesting that this line should have a pattern of methylation similar to that of B cells and macrophages.”
Rao, S., Garrett‐Sinha, L. A., Yoon, J. W., & Simon, M. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.48.34245 · Cited by 55
Ishimaru, F., & Shipp, M. (1995) · Blood · doi:10.1182/blood.v85.11.3199.bloodjournal85113199 · Cited by 42
Transcriptional regulation of hemopoiesis
Barreda, D. R., & Belosevic, M. (2001) · Developmental & Comparative Immunology · doi:10.1016/s0145-305x(01)00035-0 · Cited by 45
Repression of I-Aβ Gene Expression by the Transcription Factor PU.1
Borràs, F. E., LLoberas, J., Maki, R. A., & Celada, A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.24385 · Cited by 41
Self-citationThe promoter and 5' flanking sequences controlling human B29 gene expression
Thompson, A., Wood, W. J., Gilly, M., Damore, M. A., Omori, S., & Wall, R. (1996) · Blood · doi:10.1182/blood.v87.2.666.bloodjournal872666 · Cited by 45
Precise Alignment of Sites Required for μ Enhancer Activation in B Cells
Nikolajczyk, B. S., Nelsen, B., & Sen, R. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.8.4544 · Cited by 38
“The minimal enhancer contains the mA and mB elements that bind ETS-domain proteins (42), along with the mE3 element that binds several factors belonging to the bHLH-zip family (3, 4, 7, 16, 48, 49).”
BackgroundMethodSelf-citationThe hematopoietic transcription factor PU.1 is downregulated in human multiple myeloma cell lines
Pettersson, M., Sundstrom, C., Nilsson, K., & Larsson, L. (1995) · Blood · doi:10.1182/blood.v86.7.2747.2747 · Cited by 37
Goffin, V., Demonté, D., Vanhulle, C., de Walque, S., de Launoit, Y., Burny, A., Collette, Y., & Lint, C. V. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki720 · Cited by 37
“An SmaI–XhoI fragment containing the HIV-1 LAI 50-LTR (nt 1–789) was purified from the previously described pLTR(1-789)-luc construct (9).”
MethodQuivy, V., de Walque, S., & Lint, C. M. V. (2007) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/1-4020-5466-1_17 · Cited by 41
Thompson, H. G. R., Harris, J. W., Lin, L., & Brody, J. P. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.01.019 · Cited by 36
“In TATA-less promoters, Sp1 also interacts with other proteins other than TFIID to stimulate transcription, including E2 [30,31], NFnB [32], Oct-1 [33], SREBP-1 [34,35], and the Ets factors Ets-1 [36,37] and PU.1 [ 38 ].”
BackgroundGuan, F. H. X., Bailey, C. G., Metierre, C., O’Young, P., Gao, D., Khoo, T. L., Holst, J., & Rasko, J. E. J. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0446-7 · Cited by 37
Dekoninck, A., Calomme, C., Nizet, S., de Launoit, Y., Burny, A., Ghysdael, J., & Lint, C. M. V. (2003) · Oncogene · doi:10.1038/sj.onc.1206392 · Cited by 38
“…PU.1 have been identified in B cells (k 30 enhancer, Pongubala et al., 1992, 1993, l2–4 enhancer, Eisenbeis et al., 1993, heavy chain Em enhancer, Nelsen et al., 1993, J chain promoter, Shin and Koshland 1993, and Btk promoter, Himmelmann et al., 1996), myeloid cells (CD11b, Chen et al., 1993;…”
BackgroundPU.1 acts as tumor suppressor for myeloma cells through direct transcriptional repression of IRF4
Ueno, N., Nishimura, N., Ueno, S., Endo, S., Tatetsu, H., Hirata, S., Hata, H., Matsuoka, M., Mitsuya, H., & Okuno, Y. (2017) · Oncogene · doi:10.1038/onc.2017.79 · Cited by 34
Combinatorial Determinants of Tissue-Specific Transcription in B Cells and Macrophages
Nikolajczyk, B. S., Cortes, M., Feinman, R., & Sen, R. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.3527 · Cited by 34
“The lack of correlation between the tissue distribution of enhancer binding proteins and cells having an active enhancer led us to propose that tissue specificity of the enhancer is achieved by a combinatorial mechanism ( 26 ).”
BackgroundMethodSelf-citationInvolvement of Ets‐related proteins in hormone‐independent mammary cell‐specific gene expression
Welte, T., Garimorth, K., PHILIPP, S., Jennewein, P., Huck, C., Cato, A. C. B., & Doppler, W. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb19078.x · Cited by 34
Invasive tumors induce c‐ets1 transcription factor expression in adjacent stroma
Calmels, T., Mattot, V., Wernert, N., Vandenbunder, B., & Stéhelin, D. (1995) · Biology of the Cell · doi:10.1016/0248-4900(96)81318-9 · Cited by 32
Kihara-Negishi, F., Yamada, T., Kubota, Y., Kondoh, N., Yamamoto, H., Abe, M., Shirai, T., Hashimoto, Y., & Oikawa, T. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980518)76:4<523::aid-ijc14>3.0.co;2-8 · Cited by 32
Regulation of gene expression by transcription factors Ets‐1 and Ets‐2
Tymms, M. J., & Kola, I. (1994) · Molecular Reproduction and Development · doi:10.1002/mrd.1080390214 · Cited by 32
“l in the IgH enhancer (Nelsen et al., 1993) and c-myb in the mim-1 promoter (Dudek et al.”
BackgroundConstitutively expressed Oct-2 prevents immunoglobulin gene silencing in myeloma × T cell hybrids
Radomska, H. S., Shen, C.-P., Kadesch, T. R., & Eckhardt, L. A. (1994) · Immunity · doi:10.1016/1074-7613(94)90034-5 · Cited by 32
Context dependent transactivation domains activate the immunoglobulin mu heavy chain gene enhancer.
Erman, B., & Sen, R. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00843.x · Cited by 33
Self-citationFunctional motifs in the IgH enhancer of the channel catfish
Magor, B. G., Ross, D. A., Middleton, D. L., & Warr, G. W. (1997) · Immunogenetics · doi:10.1007/s002510050261 · Cited by 31
“Role ofµB motifs in the catfish IgH enhancer The µB motif makes a far greater contribution to the activity of the mouse Eµ enhancer than to the catfish Eµ39 enhancer when these activities are assessed in their native B cells (Libermann et al. 1990; Magor et al. 1994; Nelsen et al. 1990).”
BackgroundInfluentialXu, L., Sokalski, K. M., Hotke, K., Christie, D. A., Zarnett, O. J., Piskorz, J., Thillainadesan, G., Torchia, J., & DeKoter, R. P. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201267 · Cited by 32
“1 (39, 40), were enriched in cells expressing FLAG-tagged PU.”
BackgroundSpi-C Has Opposing Effects to PU.1 on Gene Expression in Progenitor B Cells
Schweitzer, B. L., Huang, K. J., Kamath, M. B., Emelyanov, A. V., Birshtein, B. K., & DeKoter, R. P. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2195 · Cited by 33
Dang, W., Sun, X.-H., & Sen, R. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.3.1477 · Cited by 32
“by the DEAE-dextran method (20), and whole-cell extracts were prepared 48 h”
BackgroundMethodInfluentialSelf-citationProperties of Ets-1 Binding to Chromatin and Its Effect on Platelet Factor 4 Gene Expression
Lü, J., Pazin, M. J., & Ravid, K. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.1.428-441.2004 · Cited by 28
“The activity of the CD5 promoter in T lymphocytes and the Ig- E in B lymphocytes require Ets-1 (30, 49).”
BackgroundPU.1/Spi-1 Is Essential for the B Cell-Specific Activity of the Mouse CD72 Promoter
Ying, H., Chang, J.-F., & Parnes, J. R. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.5.2287 · Cited by 28
The Igκ3′ Enhancer Is Activated by Gradients of Chromatin Accessibility and Protein Association
McDevit, D. C., Perkins, L., Atchison, M. L., & Nikolajczyk, B. S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2834 · Cited by 27
“1 is an important transcriptional activator for both the 3 enhancer and E (9, 31).”
BackgroundPU.1 as a chromatin accessibility factor for immunoglobulin genes
Marecki, S., McCarthy, K. M., & Nikolajczyk, B. S. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2003.08.007 · Cited by 25
Nozaki, M., ONISHI, Y., KANNO, N., ONO, Y., & Fujimura, Y. (1996) · DNA and Cell Biology · doi:10.1089/dna.1996.15.855 · Cited by 26
“…ets ONCOGENE (v-ets) was discovered as part of a fu-Klemsz era/., 1990; Ben-David et al, 1991; Leidener al, 1992; sion protein with gag and myb expressed by the E26 avian Koizumi et al, 1993; Nelsen et al, 1993; Rivera et al, 1993). erythroblastosis virus (Leprince et al, 1983; Nunn et al, 1983).”
Role of Ets Proteins in Development, Differentiation, and Function of T‐Cell Subsets
Liu, M., Gao, W., van Velkinburgh, J. C., Wu, Y., Ni, B., & Tian, Y. (2015) · Medicinal Research Reviews · doi:10.1002/med.21361 · Cited by 24
HMGA1 Co-activates Transcription in B Cells through Indirect Association with DNA
McCarthy, K. M., McDevit, D. C., Andreucci, A., Reeves, R., & Nikolajczyk, B. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308586200 · Cited by 23
PU.1-mediated Transcription Is Enhanced by HMG-I(Y)-dependent Structural Mechanisms
Lewis, R. T., Andreucci, A., & Nikolajczyk, B. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008726200 · Cited by 29
The transcription factor ETS1 in lymphomas: friend or foe?
Testoni, M., Chung, E. Y., Priebe, V., & Bertoni, F. (2014) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2014.981670 · Cited by 23
ELF-1 Interacts with and Transactivates the IgH Enhancer π Site
Akbarali, Y., Oettgen, P., Boltax, J., & Libermann, T. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.42.26007 · Cited by 23
The GATA-1 and Spi-1 transcriptional factors bind to a GATA/EBS dual element in the Fli-1 exon 1
Barbeau, B., Barat, C., Bergeron, D., & Rassart, É. (1999) · Oncogene · doi:10.1038/sj.onc.1202913 · Cited by 24
“The importance of the interaction of the Fli-1 EBS intronic element with its Ets-related factor for Fli-1 gene expression remains to be determined although functionally important EBS elements in intronic sequence have already been described (Nelsen et al., 1993).”
BackgroundNagulapalli, S., Goheer, A., Pitt, L. K., McIntosh, L. P., & Atchison, M. L. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.20.7337-7350.2002 · Cited by 22
Regulation of Class Switch Recombination
Cogné, M., & Birshtein, B. K. (2004) · Elsevier eBooks · doi:10.1016/b978-012053641-2/50020-4 · Cited by 23
Exploring Functional Redundancy in the Immunoglobulin μ Heavy-Chain Gene Enhancer
Dang, W., Nikolajczyk, B. S., & Sen, R. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.11.6870 · Cited by 20
Self-citationLinderson, Y., Cross, D., Neurath, M. F., & Pettersson, S. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270218 · Cited by 19
Ets-1 Activates the DRA Promoter in B Cells
Jabrane‐Ferrat, N., & Peterlin, B. M. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.11.7314 · Cited by 19
Basic helix-loop-helix proteins in murine type C retrovirus transcriptional regulation
Nielsen, A. L., Pallisgaard, N., Pedersen, F. S., & Jørgensen, P. (1994) · Journal of Virology · doi:10.1128/jvi.68.9.5638-5647.1994 · Cited by 19
Cellular and Molecular Analysis of Lymphoid Development Using RAG-Deficient Mice
Spanopoulou, E. (1996) · International Reviews of Immunology · doi:10.3109/08830189609061752 · Cited by 22
Genetic analysis of transcription factors implicated in B lymphocyte development
Singh, H. (1994) · Immunologic Research · doi:10.1007/bf02935619 · Cited by 18
“In the B lineage PU. 1 is implicated in regulating transcription of the Ig heavy (~t) [ 57 ] and light chain genes (~ and ~) [58, 59], the mb-1 gene [60, 61], and the Jchain gene [62].”
BackgroundFunctional interactions with Pit-1 reorganize co-repressor complexes in the living cell nucleus
Voss, T. C., Demarco, I. A., Booker, C. F., & Day, R. N. (2005) · Journal of Cell Science · doi:10.1242/jcs.02450 · Cited by 17
“Non-pituitary HeLa cells do not express crucial regulators of the PRL-encoding gene, including Pit-1, allowing dissection of Pit-1-dependent PRL promoter activation (Bradford et al., 1997; Ingraham et al., 1988; Nelsen et al., 1993; Walter et al., 1985).”
BackgroundJernberg‐Wiklund, H., & Nilsson, K. (2002) · Human cell culture · doi:10.1007/0-306-46877-8_4 · Cited by 18
Enhancing B-Cell Malignancies—On Repurposing Enhancer Activity towards Cancer
Kasprzyk, M. E., Sura, W., & Dzikiewicz‐Krawczyk, A. (2021) · Cancers · doi:10.3390/cancers13133270 · Cited by 15
“Although a limited region containing μA, E3, and μB is sufficient to activate transcription in B cells [31,32], the whole core enhancer element and MARs are postulated to function as locus control region (LCR) [28] and are necessary for efficient transcription of the IGH μ transcript (from VH promoter) [33–35].”
BackgroundBradford, A. P., & Gutierrez‐Hartmann, A. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-221-0_3 · Cited by 15
Enjoji, M., Iwaki, T., Hara, H., Sakai, H., Nawata, H., & Watanabe, T. (1996) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1996.tb02117.x · Cited by 14
Molecular mechanisms of extinction: old findings and new ideas
Massa, S., Junker, S., & Matthias, P. (2000) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00102-8 · Cited by 17
Analysis of Gene Function in Lymphocytes by RAG-2-Deficient Blastocyst Complementation
Chen, J. (1996) · Advances in immunology · doi:10.1016/s0065-2776(08)60427-7 · Cited by 14
Yamada, T., Suzuki, M., Satoh, H., Kihara‐Negishi, F., Nakano, H., & Oikawa, T. (2003) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.10.023 · Cited by 14
Regulation of immunoglobulin gene transcription
Calame, K. L., & Ghosh, S. (1995) · Elsevier eBooks · doi:10.1016/b978-012053640-5/50021-5 · Cited by 13
Priebe, V., Sartori, G., Napoli, S., Chung, E. Y., Cascione, L., Kwee, I., Arribas, A. J., Mensah, A. A., Rinaldi, A., Ponzoni, M., et al. (2020) · Cancers · doi:10.3390/cancers12071912 · Cited by 11
Torlakovic, E., Małecka, A., Myklebust, J. H., Tierens, A. M., Aasheim, H., Nesland, J. M., Smeland, E. B., Kvaløy, S., & Delabie, J. (2005) · The Journal of Pathology · doi:10.1002/path.1777 · Cited by 15
Transcription of Immunoglobulin Genes
Calame, K. L., & Sen, R. (2004) · Elsevier eBooks · doi:10.1016/b978-012053641-2/50007-1 · Cited by 13
Self-citationA.M.El-Gazzar, M., Maeda, K., Nomiyama, H., Nakao, M., Kuwahara, K., & Sakaguchi, N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106696200 · Cited by 11
Early B Cell Development to a Mature, Antigen-Sensitive Cell
Melchers, F., & Kincade, P. W. (2004) · Elsevier eBooks · doi:10.1016/b978-012053641-2/50008-3 · Cited by 12
Goto, H., Kariya, R., Kudo, E., Okuno, Y., Ueda, K., Katano, H., & Okada, S. (2017) · Oncogene · doi:10.1038/onc.2017.138 · Cited by 10
Hikima, J.-I., Richard, M. L., Wilson, M. R., Miller, N. W., & Warr, G. W. (2006) · Gene · doi:10.1016/j.gene.2006.03.014 · Cited by 10
Dual regulation of ets-activated gene expression by SP1
Kelley, K. M. M., Wang, H., & Ratnam, M. (2003) · Gene · doi:10.1016/s0378-1119(03)00445-1 · Cited by 9
Critical Role for the Oct-2/OCA-B Partnership in Ig-Secreting Cells
Salas, M. M., & Eckhardt, L. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6589 · Cited by 10
“All three transcription factors are expressed throughout B cell development, as represented by pre-B, B, and Ig-secreting cell lines (2, 6, 7).”
BackgroundDiverse Forms of Immunoglobulin Genes in Lower Vertebrates
Litman, G. W., Flajnik, M. F., & Warr, G. W. (2004) · Elsevier eBooks · doi:10.1016/b978-012053641-2/50028-9 · Cited by 9
Reich, L., Sharir, H., Ber, R., Wirth, T., Bergman, Y., & Laskov, R. (1996) · Somatic Cell and Molecular Genetics · doi:10.1007/bf02374372 · Cited by 8
Transcriptional Control of B Cell Activation
Corcoran, L. M. (2005) · Springer eBooks · doi:10.1007/3-540-26363-2_6 · Cited by 9
Matsudo, H., Otsuka, A., Ozawa, Y., & Ono, M. (2003) · Gene · doi:10.1016/j.gene.2003.08.021 · Cited by 8
Lawrenz-Smith, S. C., & Thomas, C. (1995) · Journal of Virology · doi:10.1128/jvi.69.7.4142-4148.1995 · Cited by 7
“For example, E47 is considered an important regulator of immunoglobulin heavy-chain gene expression, but an isolated deletion of the E47-binding site has only a minor effect on the function of the immunoglobulin heavychain gene enhancer (28, 35, 39).”
BackgroundResultInfluentialBiotechnology in Turkey: An overview
Özdamar, T. H. (2009) · Biotechnology Journal · doi:10.1002/biot.200900145 · Cited by 6
“Modeling and simulations of the structure and dynamics of biomolecular systems, sequence-struc- ture-function relationship in macromolecules, and statistical mechanics of bio-polymers, coming from a background of chemistry and physics with an engineering base are the contributions to biological sciences initiated by B…”
MethodMi2β Shows Chromatin Enzyme Specificity by Erasing a DNase I-hypersensitive Site Established by ACF
Ishii, H., Du, H., Zhang, Z., Henderson, A., Sen, R., & Pazin, M. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807617200 · Cited by 6
Self-citationIshii, H., Sen, R., & Pazin, M. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308973200 · Cited by 7
Self-citationMisregulation of the IgH Locus in Thymocytes
Kumari, G., Gerasimova, T. I., Du, H., De, S., Wood, W. H., Becker, K. G., & Sen, R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02426 · Cited by 6
Self-citationChung, E. Y., Sartori, G., Ponzoni, M., Cascione, L., Priebe, V., Xu-Monette, Z. Y., Fang, X., Zhang, M., Visco, C., Tzankov, A., et al. (2023) · British Journal of Haematology · doi:10.1111/bjh.19018 · Cited by 5
Raghunandan, R., Frissora, F. W., & Muthusamy, N. (2012) · Scandinavian Journal of Immunology · doi:10.1111/sji.12012 · Cited by 6
The transcription factor Spi-B is not required for somatic hypermutation
Kim, N., Martin, T. E., Simon, M. C., & Storb, U. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(02)00201-8 · Cited by 4
Dominant-Negative HMGA1 Blocks μ Enhancer Activation through a Novel Mechanism
Andreucci, A., Reeves, R., McCarthy, K. M., & Nikolajczyk, B. S. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6672 · Cited by 5
Epitope Mapping of Human ETS1 Monoclonal Antibody
BHAT, N. K., Romano-Spica, V., Georgiou, P., CHEN, S.-L., KUI, P. G., & Suzuki, H. (1994) · Hybridoma · doi:10.1089/hyb.1994.13.1 · Cited by 4
Identifying cis-Acting DNA Elements within a Control RegionPreprint
Carey, M., Peterson, C. L., & Smale, S. T. (2012) · Cold Spring Harbor Protocols · doi:10.1101/pdb.top068171 · Cited by 4
“They fi rst created deletion mutants to identify the smallest enhancer fragment that supports enhancer function preferentially in B cells (Nelsen et al. 1990, 1993).”
BackgroundDecreased PU.1 expression in mature B cells induces lymphomagenesis
Endo, S., Nishimura, N., Toyoda, K., Komohara, Y., Carreras, J., Yuki, H., Shichijo, T., Ueno, S., Ueno, N., Hirata, S., et al. (2024) · Cancer Science · doi:10.1111/cas.16344 · Cited by 4
A xenograft model reveals that PU.1 functions as a tumor suppressor for multiple myeloma in vivo
Nishimura, N., Endo, S., Ueno, S., Ueno, N., Tatetsu, H., Hirata, S., Hata, H., Komohara, Y., Takeya, M., Mitsuya, H., et al. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.03.124 · Cited by 3
Pasare, C., Noggle, S., Entringer, M. A., Heinzelmann, A., Bansal, P., George, A., Bal, V., Rath, S., & Durdik, J. M. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199904)29:04<1219::aid-immu1219>3.0.co;2-h · Cited by 2
Enjoji, M. (1994) · Molecular and Cellular Biochemistry · doi:10.1007/bf00926037 · Cited by 2
“They conclude that in murine ENH~H the laA and lab elements together define an enhancer domain whose activity is increased in proportion to the number of proximal E elements [ 16 ].”
BackgroundMethodInfluentialHikima, J.-I., Richard, M. L., Wilson, M. R., Miller, N. W., & Warr, G. W. (2008) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2008.04.001 · Cited by 2
“The core region of the catfish Eμ3′ enhancer differs in position, structure and function from the mammalian intronic IGH enhancer, Eμ [1,2,7,8].”
BackgroundChanges in immunoglobulin–nucleoprotein complex structure mapped by chromatin immunoprecipitation
McDevit, D. C., & Nikolajczyk, B. S. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2005.10.003 · Cited by 3
Batista, C. R., & DeKoter, R. P. (2017) · Springer eBooks · doi:10.1007/978-3-319-67199-4_101960 · Cited by 2
Ma, F., Braikia, F.-Z., & Sen, R. (2024) · Frontiers in Epigenetics and Epigenomics · doi:10.3389/freae.2024.1489362 · Cited by 1
Self-citationThe Role of PU.1 in the Regulation of Lymphoid and Myeloid Hematopoietic Progenitors
Scott, E. W. (1998) · Humana Press eBooks · doi:10.1007/978-1-4757-2778-4_7 · Cited by 1
Transcriptional Control of B-Cell Differentiation by EBF and E2A
Sigvardsson, M., & Grosschedl, R. (1998) · Humana Press eBooks · doi:10.1007/978-1-4757-2778-4_5 · Cited by 1
Metadata
- Authors
- Nelsen, B., Tian, G., Erman, B., Gregoire, J., Maki, R., Graves, B., & Sen, R.
- Affiliations
- Brandeis University (US)
- University of Utah (US)
- Sanford Burnham Prebys Medical Discovery Institute (US)
- Venue
- Science
- Published
- 1993-07-02
- Volume
- 261
- Issue
- 5117
- Pages
- 82-86
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2041497115
- Cited by
- 222
- References
- 34
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 2 · 2018: 1 · 2017: 5 · 2016: 1 · 2015: 1 · 2014: 3 · 2012: 3
- FWCI
- 9.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k04gm000563-03)
- National Institute of General Medical Sciences (GM 38663, GM-38925, 1K04GM00563)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- enhancer regulation, ETS transcription factors, ETS1, pre-B cell differentiation, B cell development, transcriptional activation
- MeSH terms
- Proto-Oncogene Mas, Animals, B-Lymphocytes, Base Sequence, Binding Sites, Cell Differentiation, Cell Line, DNA-Binding Proteins, Enhancer Elements, Genetic, Female, Genes, Immunoglobulin, Humans, Immunoglobulin mu-Chains, Molecular Sequence Data, Mutation, Proto-Oncogene Proteins, Transcription Factors, Retroviridae Proteins, Oncogenic, Proto-Oncogene Proteins c-ets, Proto-Oncogene Protein c-ets-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.